BDNF and Alzheimer disease: Patients with amnestic mild cognitive impairment develop AD associated with an increase of DNA methylation on Bdnf promoter, which can be responsible for the reduction of mRNA or protein levels of BDNF [97], indicating that a higher methylation is associated with a lower mRNA expression.